April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Determination of Tear and Serum Inflammatory Cytokines in Patients with Rosacea Using Luminex Technology
Author Affiliations & Notes
  • P. Topcu Yilmaz
    Ophthalmology, Wilmer Eye Institute, Baltimore, Maryland
  • N. Atakan
    Dermatology,
    Hacettepe University School of Medicine, Ankara, Turkey
  • B. Bozkurt
    Ophthalmology, Selcuk University, Meram Medical Faculty, Konya, Turkey
  • M. Irkec
    Ophthalmology,
    Hacettepe University School of Medicine, Ankara, Turkey
  • L. Mesci
    Pediatrics,
    Hacettepe University School of Medicine, Ankara, Turkey
  • D. Aban
    Ophthalmology,
    Hacettepe University School of Medicine, Ankara, Turkey
  • I. Tezcan
    Pediatrics,
    Hacettepe University School of Medicine, Ankara, Turkey
  • Footnotes
    Commercial Relationships  P. Topcu Yilmaz , None; N. Atakan, None; B. Bozkurt, None; M. Irkec, None; L. Mesci, None; D. Aban, None; I. Tezcan, None.
  • Footnotes
    Support  TUBITAK (The Scientific and Technological Research Council of Turkey)-107S312 (SBAG-HD-259)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3592. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Topcu Yilmaz, N. Atakan, B. Bozkurt, M. Irkec, L. Mesci, D. Aban, I. Tezcan; Determination of Tear and Serum Inflammatory Cytokines in Patients with Rosacea Using Luminex Technology. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3592.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To compare the levels of inflammatory cytokines in serum and tear fluid samples between the rosacea subjects and healthy controls.

Methods: : Thirty patients with rosacea and 22 healthy controls were included in the study. All subjects underwent a dermatological and ophthalmological examination. Serum and minimally stimulated tear samples were obtained from each subject and Luminex technology was used to measure the interleukin (IL)-1, IL-6, IL-8, IL-10, monocyte chemotactic protein-1 (MCP-1), macrophage inhibitory protein-1 (MIP-1), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) cytokine levels.

Results: : Blepharitis, conjunctival hyperemia, meibomian gland dysfunction and telengiectasia were observed in 53.1%, 56.3%, 37.5% and 21.9% of the rosacea group, respectively. Serum IL-8 level was significantly higher in the rosacea group (15.53±67.83 pg/ml) than the control group (6.56±10.35 pg/ml) (p=0.03). Tear concentrations of IL-10 and VEGF were lower in the rosacea group (42.82±39.63 and 390.21±140.91 pg/ml, respectively) than the control group (202.64±546.03 and 524.88±192.39 pg/ml, respectively) (p<0.001 and p=0.005, respectively).

Conclusions: : Increased level of serum IL-8, which is a potent chemotactic cytokine, might support the role of infectious agents in the pathogenesis of rosacea. The cytokine levels show a high variation within the population; therefore bigger sample size is needed to confirm the association of cytokines with rosacea.

Keywords: cornea: tears/tear film/dry eye • cytokines/chemokines • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×